- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Lenalidomide – March 2016
Lenalidomide: 5 mg capsule, 10 mg capsule, 15 mg capsule, 25 mg capsule, Revlimid®
Last updated
1 July 2016